Natriumoxybaat Kalceks (Sodium Oxybate)

Sodium Oxybate, the active ingredient in Natriumoxybaat Kalceks, is a GABA_B receptor agonist presented as an oral formulation for oral use. It is indicated for the treatment of narcolepsy with cataplexy, helping to improve nighttime sleep continuity and reduce daytime cataplexy episodes.

GNH USA supplies Natriumoxybaat Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides full regulatory documentation and reliable support to facilitate import and distribution.

Sodium Oxybate acts on the central nervous system to treat disorders of sleep regulation, particularly narcolepsy with cataplexy. - Narcolepsy with cataplexy: improves nighttime sleep continuity and reduces cataplexy episodes. - Cataplexy attacks (narcolepsy subtype): decreases frequency and severity of sudden muscle weakness. - Excessive daytime sleepiness (narcolepsy): enhances daytime alertness and functional performance.

Sodium Oxybate may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Insomnia: difficulty initiating sleep. - Weight loss: reduced appetite or caloric intake. - Anxiety: feelings of nervousness or tension.

Serious or Rare Side Effects: - Respiratory depression: reduced breathing effort, especially with concurrent depressants. - Seizures: rare occurrence of convulsive episodes. - Hallucinations or psychosis: altered perception or mental status. - Severe hypotension: marked drop in blood pressure. - Allergic reactions: rash, swelling, or anaphylaxis.

When prescribing Sodium Oxybate, clinicians should consider several safety measures. - Monitor respiratory function: patients with sleep‑disordered breathing may experience worsening. - Avoid alcohol: concurrent use can cause additive central nervous system depression. - Assess renal function: impaired clearance may require dose adjustment. - Use caution in depression: increased risk of suicidal ideation has been reported. - Pregnancy: limited data; use only if the potential benefit justifies the potential risk. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Sodium Oxybate can interact with other medications, necessitating careful review.

Major Interactions (Avoid): - Alcohol: additive CNS depression leading to severe sedation. - Opioids: heightened risk of respiratory depression and overdose. - Benzodiazepines: enhanced sedative effects and possible respiratory compromise.

Moderate Interactions (Monitor Closely):\n- Antidepressants (SSRIs, SNRIs): may increase risk of serotonin syndrome. - Antihypertensives: potential potentiation of hypotensive effects. - CYP2C19 inhibitors: may raise plasma concentrations of Sodium Oxybate.